Klotho Neuroscience Inc. Expands Focus Beyond Neurology to Enhance Muscle Strength, Bone Health, and Longevity

Reuters
07-25
Klotho Neuroscience Inc. Expands Focus Beyond Neurology to Enhance Muscle Strength, Bone Health, and Longevity

Klotho Neurosciences, Inc. (NASDAQ: KLTO) has announced plans to broaden its development programs beyond neurology to include technologies aimed at enhancing muscle strength, bone health, and other indicators of longevity. The company is exploring the acquisition of complementary technologies to support healthy brain function, organ health, and overall longevity. In addition to its core focus on neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's, Klotho aims to expand its anti-aging platform to slow biological aging and mitigate age-related diseases. The company's efforts will include research into key longevity indicators like alpha-Klotho, beta-Klotho, and FOXO3, with the intention of promoting healthier, longer lives.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA37306) on July 24, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10